| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ARHGEF12 mRNA | affects expression | 21346803
|
| D001151 |
Arsenic |
ARHGEF12 mRNA results in increased susceptibility to Arsenic | increases response to substance | 17976673
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ARHGEF12 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 17942748
|
| C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 16996129
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 17183730
|
| C051890 |
irinotecan |
irinotecan analog results in decreased expression of ARHGEF12 mRNA | decreases expression | 18927307
|
| D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of ARHGEF12 mRNA | decreases expression | 18158353
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARHGEF12 mRNA | affects binding|increases activity|increases expression | 19710929
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of ARHGEF12 mRNA | decreases expression | 20308225
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 17942748
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 17183730
|
| C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA | affects cotreatment|increases expression | 16996129
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.83 | 14514962 11752688 15322242 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.83 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.04 | 19490988 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
| MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.57 | 19715164 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
| MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.64 | 20200999 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.87 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
14.38 | 17306315 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
14.38 | 16712894 17306315 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.41 | 17688650 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.66 | 17497229 |
| MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.21 | 17460149 |
| MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.89 | 16835338 12569548 16251483 18414634 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
| MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.31 | 12928151 19371607 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18985861 20603192 17507914 19460635 15238991 19232924 18558336 18396377 18775368 18940202 17688650 17157402 18177632 16609825 18316065 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.13 | 17594078 20046352 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.25 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.25 | 8888407 |
| MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.07 | 19442620 16778634 16121404 17312309 15867366 11697798 |
| MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.81 | 16769263 18496637 15845617 8053405 11869084 18404659 |
| MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.70 | 15306635 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
2.35 | 18695136 16096432 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
| MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.65 | 17687452 15504454 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.75 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.75 | 16507464 17306315 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.75 | 15276417 17306315 16507464 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.57 | 19233551 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
3.90 | 18507039 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.93 | 15504454 18922899 17687452 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.93 | 18572023 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.18 | 18640142 |
| MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
7.07 | 17124262 16170337 15728586 17287366 11754973 11179087 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
7.07 | 18670907 18850075 16120746 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.52 | 19152805 15738583 17938729 |
| MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.41 | 18022660 16973168 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.99 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.99 | 19524636 20056578 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.74 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.01 | 17110522 16919318 15861022 16105132 11677210 17681005 17333356 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.01 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 15340226 12621046 8697196 15668235 16354765 |
| MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.61 | 17287894 17725105 |
| MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 18509181 15273666 18259882 16391804 17159606 17454858 16303861 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
| MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.88 | 16142594 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 20055451 15322242 10048152 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.50 | 16575769 17688650 8888407 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.37 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.37 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.37 | 1733752 19641884 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.17 | 1851702 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 15322242 16714409 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.29 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.09 | 3922381 16628512 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.99 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.68 | 7562514 6254150 6426943 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.44 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.22 | 3659116 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.71 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.71 | 19236843 20131406 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.71 | 14986274 19224547 |
| MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.98 | 16234978 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.06 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.26 | 18558336 8888407 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
| MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.73 | 6392382 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.83 | 16452187 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 19176532 18467677 16221962 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 12621046 15340226 16120746 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.25 | 12676792 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.02 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 16354765 15340226 18606429 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.33 | 16769263 |
| MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.16 | 19622757 18089816 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
| MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.56 | 17050553 |
| MESH:D006973 |
Hypertension |
|
Arsenic |
8.94 | 16076760 11953799 9931084 |
| MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.94 | 12717712 8949925 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.94 | 18670907 18850075 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.76 | 16612254 |
| MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.66 | 18502941 12791704 |
| MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.73 | 16093927 |
| MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.37 | 12669777 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.88 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
| MESH:D007642 |
Keratosis |
|
Arsenic |
5.14 | 16930632 12749816 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.86 | 20008137 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.07 | 16705839 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.88 | 18089816 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.62 | 17339181 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.56 | 11134558 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.66 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
14.66 | 16368122 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.66 | 15890375 16377806 20007298 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
14.66 | 15276417 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.66 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.95 | 6135515 2876786 2876784 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.24 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.44 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
3.51 | 19168569 17976673 17306315 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.51 | 17077188 16712894 17306315 15276417 19931552 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 19555203 11884234 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
3.79 | 17312309 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.04 | 19082730 16487513 |
| MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.79 | 16675582 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.27 | 18803445 18765137 |
| MESH:D052016 |
Mucositis |
|
irinotecan |
5.16 | 17159606 |
| MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
8.43 | 16996129 |
| MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
8.43 | 18089719 19621390 16996129 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.14 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.21 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.30 | 15371236 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.30 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 18551238 7678174 |
| MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
6.49 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
6.49 | 15867366 17312309 19139120 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.11 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.11 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.80 | 20056578 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
12.62 | 16620997 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
12.62 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
12.62 | 8888407 16359493 |
| MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.53 | 8761367 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.88 | 8761367 |
| MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.49 | 17056641 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
| MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.52 | 15867366 |
| MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.10 | 17882678 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.13 | 17306315 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.13 | 17306315 15276417 |
| MESH:D010146 |
Pain |
|
zoledronic acid |
4.03 | 16475674 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.30 | 16093927 |
| MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.14 | 6392382 16905509 15371236 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.98 | 11399792 11118676 11222880 11896295 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.98 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.75 | 16140617 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.75 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.75 | 12438248 19103299 |
| MESH:D011507 |
Proteinuria |
|
Arsenic |
4.12 | 21343184 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.71 | 11422049 12752131 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.29 | 19155313 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.06 | 16121404 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.19 | 18551238 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
6.19 | 1511512 17978042 14763951 11738929 3137016 16876388 11044598 15475178 |
| MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.86 | 7327846 |
| MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.77 | 17938729 17548696 16353154 19834688 16759981 15952646 16702368 17050553 6392382 18709164 17453740 |
| MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.77 | 16251483 19538983 17050553 15504454 17976673 17029826 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.77 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.77 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.83 | 12854658 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.83 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.71 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.36 | 15723263 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.41 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.67 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.61 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.61 | 19322015 19429237 15987713 18640142 17976673 17306315 11144890 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.61 | 17306315 11723127 16712894 16452187 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.78 | 8888407 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.87 | 11813266 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
| MESH:D014652 |
Vascular Diseases |
|
Arsenic |
12.37 | 17056641 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
12.37 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |